Powered by
EAST LANSING—Quantum Medical Concepts, an early-stage investment fund in health care companies established by the Michigan State Medical Society and the Lansing business advisory firm Common Wealth Enterprises, announced new …
JACKSON—U.S. Secretary of Commerce Gina Raimondo announced this week that a total of $29 million would be awarded to 44 organizations as part of the Economic Development Administration’s (EDA) Scaling …
ANN ARBOR–The 2021 Midwest Venture Showcase returns April 27-28, 2021, to highlight industry trends, expert insights, and growing Midwest companies seeking venture capital investments. The Midwest Growth Capital Symposium and …
ANN ARBOR—Esperion Therapeutics Inc. reported a loss of $85.4 million or $3.07 a share in the third quarter of 2020, vs. a loss of $68.4 million or $2.52 a share …
FLINT—XlerateHealth, a national healthcare startup accelerator based in Louisville, Ky., announced the selection of six startup companies to its second annual cohort in Flint. The companies will participate in a …
EAST LANSING—The Michigan State University Foundation’s Conquer Accelerator announced the launch of its fifth season and summer 2020 cohort. The 10-week accelerator welcomes five selected teams to its East Lansing …
ANN ARBOR—The Michigan “angel investor” community released its 2019 annual research report, showing an increase in the number of angel investors and the amount they invested in Michigan startups last …
ANN ARBOR—The Michigan Growth Capital Symposium, the Midwest’s oldest and largest event for young companies seeking capital, will be held online Tuesday, May 5 as the Midwest Venture Showcase 2020. …
ANN ARBOR—After years of development, Nexletol, the new cholesterol-reducer from Ann Arbor’s Esperion Therapeutics Inc., is now on the market and available in pharmacies in the United States. Nexletol uses …
ANN ARBOR—Esperion Therapeutics Inc. (Nasdaq: ESPR) announced U.S. Food and Drug Administration approval of Nexlizet, a combination tablet of Esperion’s new non-statin cholesterol reducing drug bempedoic acid and an earlier …